Company Filing History:
Years Active: 2024-2025
Title: Leila Noetzli: Innovator in RNAi Technology
Introduction
Leila Noetzli is a prominent inventor based in Boston, MA, known for her contributions to the field of RNA interference (RNAi) technology. With a total of two patents to her name, she has made significant strides in developing innovative solutions for treating KHK-associated disorders.
Latest Patents
Her latest patents focus on Ketohexokinase (KHK) iRNA compositions and methods of use thereof. The inventions relate to RNAi agents, specifically double-stranded RNA (dsRNA) agents, that target the ketohexokinase (KHK) gene. These patents outline methods for using such RNAi agents to inhibit the expression of the KHK gene, providing potential therapeutic avenues for treating or preventing disorders associated with KHK.
Career Highlights
Leila Noetzli is currently employed at Alnylam Pharmaceuticals, Inc., where she continues to advance her research in RNAi technology. Her work is pivotal in the development of novel treatments that leverage the power of RNA interference to address complex health issues.
Collaborations
Throughout her career, Leila has collaborated with notable colleagues, including James D McIninch and Frederic Tremblay. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Leila Noetzli's contributions to RNAi technology and her innovative patents position her as a key figure in the field. Her work at Alnylam Pharmaceuticals, Inc. exemplifies the impact of dedicated inventors in advancing medical science.